Approval · Notice of Compliance 36056 · 2025
TYRUKO: Notice of Compliance 36056
Issued September 24, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36056
- Date
- September 24, 2025
- Company
- Polpharma Biologics S.A.Gdansk, --, Poland
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- TYSABRI
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TYRUKO | 02561123 | Approved |
Medicinal ingredients
- NATALIZUMAB 300 MG per 15ML